Can (Martin) Zhang, Changning Wang, | 2023

Characterization of CNS-Penetrant HDAC11-Selective Inhibitors in Alzheimer’s Disease Models

Tamir Ben-Hur, Herve Bercovier, | 2023

A Proposal to Evaluate the Effect of Bacillus Calmette-Guérin Vaccination on Alzheimer’s Disease Development

Liisa Galea, Annie Ciernia, | 2022

Combined Hormone Therapy as a Novel Treatment for Alzheimer’s Disease in the Face of a Metabolic Challenge: Influence of Sex and Genotype

Mehdi Jorfi, Joseph Park, Rudy Tanzi, | 2021

Development of a Multicellular Brain Model to Study Brain-Vascular-Peripheral Immune Cells Crosstalk in Alzheimer’s Disease

Kevin Rynearson, | 2021

Continuing Studies of the Effects of GSM 776890 Administration on Amyloid Species and Microgliosis in Older Alzheimer’s Model Mice

Jeffrey Savas, | 2021

Interrogating Levetiracetam’s Impact on Amyloid Pathology and Presynaptic Proteostasis in Knock-In Mouse Models with Humanized Amyloid Beta

Raja Bhattacharyya, Rudy Tanzi, | 2021

Effects of Depalmitoylation and ACAT Inhibition on Axonal Amyloid Beta Generation Via MAM-Associated palAPP

Deepak Kumar Vijaya Kumar, Nanda Kumar Navalpur Shanmugam, Rudy Tanzi, William Eimer, | 2020

Characterizing Gut Microbiome Synergy With Emphasis on Mycobiome and Its Impact on Alzheimer’s Disease (AD) Pathology in AD Mouse Models